We are committed to providing a safe and healthy environment for attendees of our upcoming events and we are actively monitoring the development and impact of the Coronavirus on the ability for all to travel and attend safely. We are planning for our event to occur on schedule, though we recognize that the situation is rapidly evolving and we are actively reviewing options to hold meetings virtually, should that become a necessity. If the situation changes, we will update this statement and inform attendees. Read the FAQ.
This conference will convene stakeholders across industry, academia, and government agencies to explore the business, regulatory, and technical aspects associated with adopting novel manufacturing platforms to produce medicines.